Biotech News
Related news
SEERSeer, Inc2026-04-09 12:00 EST
Seer and Precision Health Research, Singapore Sign Collaboration to Provide Deep, Unbiased Proteomics on 10,000 PRECISE SG100K Samples
SEERSeer, Inc2026-06-22 11:00 EST
Seer and Korea University Present Preliminary Data at ASMS 2026 Demonstrating Potential of AI-Driven Plasma Proteomics for Multi-Cancer Screening
Seer, Inc
Deep Proteomics Company Seer develops tools for large-scale, unbiased analysis of the proteome across research, translational medicine, and drug development. Proteograph Product Suite The Proteograph platform combines engineered nanoparticles, automated sample processing, consumables, and analytical software to capture proteins across a...
Recent company news
SEERSeer, Inc2026-11-10 21:05 EST
Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance
SEERSeer, Inc2026-11-05 12:00 EST
Seer Secures Key Victory in ITC Patent Dispute as Investigative Staff Backs All Requested Remedies Against Nanomics
SEERSeer, Inc2026-10-29 20:30 EST
Seer to Remain an Independent Public Company Following Conclusion of Special Committee Review Process
SEERSeer, Inc2026-10-21 20:05 EST
Seer to Report Third Quarter 2026 Financial Results on November 10, 2026
SEERSeer, Inc2026-09-23 11:00 EST
Seer and Nanyang Technological University to Present Early Findings from Landmark PRECISE-SG100K Proteomics Study at HUPO 2026
Stock data
- Close
- 1.39 USD
- Market cap
- 102.82M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States
